Next events
ILSI BIOMED ::June, 14-16::Tel Aviv, Israel
The Annual Morrison & Foerster- PricewaterhouseCoopers Israel Global Corporate Finance Seminar
Euro Biotech Forum:: June, 28-30:: Paris, France
News Categories
-
Recent Sector News
- Eisai Announces Positive Results of Phase III Trial for Perampanel in Epilepsy
- Body clock “drugs” could ease psychiatric disorders and jet lag
- Kamada reaches rights agreement with Baxter
- Roche and Aileron Alliance to Develop Stapled Peptide Drugs for Multiple Therapeutic Areas
- Galapagos and University of Bristol enter drug discovery collaboration in chronic pain.Total contract value: €3.3 million
- AVI BioPharma Closes New Contract With U.S. Government for Development of Therapeutic Candidates for Ebola and Marburg Hemorrhagic Fever Viruses
- Watson and Itero Enter Worldwide License Agreement on Biologic Development Candidate For Female Infertility
- Aricept long acting formulation benefits patients with advanced Alzheimer
- Calithera Biosciences Closes $40 Million in Series A Financing for the treatment of cancer
- Infinity and Intellikine sign $488M pact on Intellikine’s PI3K portfolio in cancer and inflammatory diseases
- Merck announced plans to phase out operations at eight research sites and eight manufacturing sites
- Sanofi creates 300 new jobs and invests $65M in Boston HQ expansion
-
-
-
Copyright Kerentech